NYKODE TOLERANCE NORWAY AS
934454618ActivePioneering immunotherapy platform unlocking future medicine for serious diseases.
Biotechnology Companynykode.com
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2024
- Grundat
Nyckelbeslutsfattare
Michael Engsig
Chief Executive Officer
Harald Gurvin
Chief Financial Officer
Louise Stubbe
Chief Legal Officer
Agnete B. Fredriksen
Chief Scientific Officer & Business Development
Beskrivning
Nykode Therapeutics ASA is a biotechnology company dedicated to advancing human health through innovative medical science. The core of their operation is the proprietary Vaccibody molecule, which forms an unrivalled modular technology platform. This platform is designed to induce fast, strong, and l...
Oncotech Nordic AB